Omarigliptin

CHEMBL2105762 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

398.4 g/mol

LogP

0.3

Phase

4

A long-acting DPP-4 inhibitor taken once weekly to improve blood sugar control in adults with type 2 diabetes, available in Japan. It works by increasing levels of incretin hormones, which stimulate insulin release and suppress glucagon after meals.

Masse moléculaire

398,4000 g/mol

LogP

0,30

TPSA

98,80 Å²

Règle des 5 de Lipinski

Conforme

Aires thérapeutiques

Type 2 Diabetes

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CS(=O)(=O)n1cc2c(n1)CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2

InChI

InChI=1S/C17H20F2N4O3S/c1-27(24,25)23-7-10-6-22(8-16(10)21-23)12-5-15(20)17(26-9-12)13-4-11(18)2-3-14(13)19/h2-4,7,12,15,17H,5-6,8-9,20H2,1H3/t12-,15+,17-/m1/s1

Molecular Formula

C17H20F2N4O3S

HBD / HBA

1 / 8

Liaisons Rotatives

3

Atomes Lourds

27

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

A long-acting DPP-4 inhibitor taken once weekly to improve blood sugar control in adults with type 2 diabetes, available in Japan. It works by increasing levels of incretin hormones, which stimulate insulin release and suppress glucagon after meals.

Yes, Omarigliptin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2105762. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 46209133. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Omarigliptin sur PillFYI

Structure

Données Clés

Formule: C17H20F2N4O3S

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.